On Consensus and Funding

A few days ago I picked up a copy of Time magazine, which featured several of the most prominent scientists of this century. One of the most prominent was, of course, Albert Einstein. Then later, I read the Opinion page by Nejat Düzgünes in the April 12 issue of The Scientist.1 The juxtaposition of these two articles got me thinking: What would have happened if Albert Einstein had been required to submit to a funding agency in Switzerland a grant proposal to study relativity but under

Written byRoger Floyd
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A few days ago I picked up a copy of Time magazine, which featured several of the most prominent scientists of this century. One of the most prominent was, of course, Albert Einstein. Then later, I read the Opinion page by Nejat Düzgünes in the April 12 issue of The Scientist.1 The juxtaposition of these two articles got me thinking: What would have happened if Albert Einstein had been required to submit to a funding agency in Switzerland a grant proposal to study relativity but under the same requirements and documentation of funding agencies today? He wouldn't have stood a chance of being funded.

Consider:

But there is more to the granting agencies than the narrowness of view, or the other requirements that Dr. Einstein could not meet. For example, I once submitted a grant proposal to a federal agency to study the effects of nitric oxide on a particular ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina

Products

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo